De­fense De­part­ment en­lists Evotec to make new an­ti­body treat­ments for Mpox and oth­er pox­es

Last year
Deals
R&D

CD­MO Adare Phar­ma So­lu­tions di­vests its post­bi­ot­ic di­vi­sion

Last year
Deals
Manufacturing

J&J tack­les med­ical il­lus­tra­tion in­equity with free data­base of di­verse im­ages

Last year
Pharma
Marketing

Am­gen and Hori­zon call FTC's at­tempt to block $28B merg­er un­con­sti­tu­tion­al in coun­ter­claims

Last year
Pharma
Law

FDA says Ip­ca Labs failed to ad­dress qual­i­ty is­sues with bad API batch­es

Last year
FDA+
Manufacturing

J&J will ad­vance pso­ri­a­sis drug li­censed from Pro­tag­o­nist af­ter fuller Phase IIb read­out

Last year
R&D
Pharma

Hong Kong SPAC nix­es di­ag­nos­tics merg­er; Clay Sie­gall will run a pub­lic biotech again

Last year
News Briefing

Chi­na ap­proves BC­MA CAR-T ther­a­py for mul­ti­ple myelo­ma, with In­novent beat­ing Leg­end in race to be first

Last year
China
Cell/Gene Tx

Swedish man­u­fac­tur­er ac­quires Val­ne­va fa­cil­i­ty

Last year
Deals
Manufacturing

No­va­cyt makes cash of­fer for fel­low UK di­ag­nos­tics com­pa­ny as Covid-19 test­ing rev­enue dwin­dles

Last year
Deals

As­traZeneca, Dai­ichi Sankyo claim PhI­II lung can­cer win for their next big ADC — but shares fall

Last year
R&D

Di­ver­si­ty of Hu­mi­ra biosim­i­lar launch­es re­veals the dif­fi­cul­ty of de­thron­ing Ab­b­Vie's megablock­buster

Last year
Pharma

DNA syn­the­sis up­start rais­es $10M to scale op­er­a­tions

Last year
Financing

Cell ther­a­py for di­a­betes: New da­ta, ap­proval, buy­out; GLP-1 race in weight loss reach­es new stage; FDA fi­nal­ly ...

Last year
Weekly

FDA in­spec­tion at In­dia phar­ma at cen­ter of the cis­platin short­age cites mul­ti­ple qual­i­ty is­sues

Last year
R&D
Manufacturing

Re­vance Ther­a­peu­tics push­es Botox 'breakup' in lat­est cam­paign for ri­val cos­met­ic drug

Last year
Pharma
Marketing

FDA and EMA chief med­ical of­fi­cers don’t ex­pect Chat­G­PT to help with drug re­views any­time soon

Last year
FDA+

CSPC to launch Paxlovid ver­sion in Chi­na; SEC charges ex-Pfiz­er em­ploy­ee with in­sid­er trad­ing

Last year
China
Coronavirus

Fol­low­ing con­tro­ver­sy, new Bio­gen di­rec­tor Su­san Langer won fewest votes from share­hold­ers

Last year
People

Eu­ro­pean Com­mis­sion so­lid­i­fies vac­cine man­u­fac­tur­ing plans to pre­pare for fu­ture health emer­gen­cies

Last year
Pharma
Coronavirus

No­var­tis-led group de­vel­ops new class of an­tipar­a­sitic drug tar­get­ing dis­eases caused by try­panosomes

Last year
R&D
Discovery

Gen­fit, Ipsen tout piv­otal tri­al read­out for rare liv­er dis­ease, head to­ward FDA and EMA sub­mis­sions

Last year
R&D

Can­cer biotech In­ten­si­ty Ther­a­peu­tics looks to pull in $16M+ IPO

Last year
Financing
R&D

Madri­gal seeks ac­cel­er­at­ed ap­proval for ex­per­i­men­tal NASH treat­ment a week af­ter In­ter­cept re­jec­tion

Last year
R&D
FDA+
First page Previous page 317318319320321322323 Next page Last page
A service from the Financial Times